via Top India News- News18.com
https://ift.tt/2TgxsI0
The therapy is most suited for "high-risk COVID patients" within the first 10 days of the symptom onset and meet any of the listed criteria like age being 65 years.
June 09, 2021 at 11:00PM
Top India News- News18.com
https://ift.tt/2xHgTtr
The therapy is most suited for "high-risk COVID patients" within the first 10 days of the symptom onset and meet any of the listed criteria like age being 65 years.
Monoclonal Antibody Therapy Improved Parameters in 2 Covid Patients Within 12 Hrs: Delhi Hospital
https://ift.tt/2TgxsI0
The therapy is most suited for "high-risk COVID patients" within the first 10 days of the symptom onset and meet any of the listed criteria like age being 65 years.June 09, 2021 at 11:00PM
Top India News- News18.com
https://ift.tt/2xHgTtr
The therapy is most suited for "high-risk COVID patients" within the first 10 days of the symptom onset and meet any of the listed criteria like age being 65 years.Monoclonal Antibody Therapy Improved Parameters in 2 Covid Patients Within 12 Hrs: Delhi Hospital
0 Comments